JFG
EDIT icon

Jefferies Financial Group’s Editas Medicine EDIT Stock Holding History

Jefferies Financial Group’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-115,500
Closed -$1.02M – 1720
2022
Q4 		$1.02M Buy
+115,500
New +$1.27M 0.01% 869

Other funds holding EDIT

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Jefferies Financial Group's EDIT Position: Q1 2024 in Review

Jefferies Financial Group sold out of Editas Medicine (EDIT) in Q1 2024, closing a stake of 25,100 shares — an estimated $254K sold.

Jefferies Financial Group first reported a position in EDIT in Q4 2022 and held it in 4 quarters. The position peaked at $924K in Q4 2022. 225 funds tracked by Wall St. Rank hold EDIT as of Q1 2024.

  • Jefferies Financial Group reported no remaining Editas Medicine position as of Q1 2024 after selling out during the quarter.
  • Jefferies Financial Group sold 25,100 Editas Medicine shares in Q1 2024, an estimated $254K.
  • Jefferies Financial Group first reported a position in Editas Medicine in Q4 2022 and held it in 4 quarters.
  • Jefferies Financial Group's Editas Medicine position peaked at $924K in Q4 2022.
  • 225 funds tracked by Wall St. Rank held Editas Medicine as of Q1 2024.

Based on Jefferies Financial Group's 13F filing for Q1 2024, filed 13 May 2024.